3 Einträge gefunden

1. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
2. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

   1. Burdelski, Christoph
   2. Ruge, Oliver M
   3. Melling, Nathaniel
   4. Koop, Christina
   5. Simon, Ronald
   6. Steurer, Stefan
   7. Sauter, Guido

   2015 - Forschungsinformationssystem des UKE
3. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich